ISO 35001:2019 - Biorisk Management for Laboratories Lead Auditor Free Practice Test — 30 Questions

Question 1

During an audit of a high-containment research laboratory, an auditor is reviewing the documented information related to the laboratory\'s biorisk management system (BRMS). The laboratory is working with novel zoonotic agents and is subject to stringent national biosafety regulations. The auditor needs to assess the effectiveness of the laboratory\'s approach to understanding its operational context as required by ISO 35001:2019. Which of the following would be the most critical piece of evidence to confirm compliance with the standard\'s intent in this area?

Accepted Answer

A comprehensive matrix detailing external regulatory requirements, emerging scientific literature on pathogen transmissibility, and internal resource allocation for safety equipment, explicitly linked to the BRMS's scope and objectives.

Question 2

During an audit of a high-containment biosafety laboratory, a lead auditor is examining the records of the top management\'s periodic review of the biorisk management system. The auditor notes that the review meeting minutes primarily discuss operational expenditures and personnel scheduling, with only a brief mention of incident reports. Which aspect of the management review process, as defined by ISO 35001:2019, is most likely deficient, indicating a potential nonconformity?

Accepted Answer

The review's focus on the suitability, adequacy, and effectiveness of the biorisk management system in achieving its objectives.

Question 3

During an audit of a high-containment biosafety laboratory, a lead auditor is reviewing the personnel competence framework for individuals handling novel viral vectors. The laboratory has implemented a robust training program, but the auditor notes that the process for *ongoing* verification of competence, particularly for individuals transitioning between different project phases involving varying levels of risk, appears to be primarily based on self-assessment and infrequent formal reviews. Considering the principles of ISO 35001:2019, which of the following approaches would best demonstrate the laboratory\'s commitment to maintaining and enhancing personnel competence in line with the standard\'s requirements for effective biorisk management?

Accepted Answer

Establishing a structured competency matrix that maps specific skills and knowledge against defined risk levels for each task, coupled with regular, documented performance observations and feedback sessions conducted by supervisors or designated competent persons.

Question 4

During an audit of a high-containment biosafety laboratory, an auditor is reviewing the laboratory\'s biorisk management system (BRMS) documentation. The laboratory handles novel zoonotic viruses and is located in a densely populated urban area. Which of the following aspects would be most critical for the lead auditor to verify regarding the laboratory\'s understanding of its context and interested parties, as per ISO 35001:2019?

Accepted Answer

Evidence of a documented process for identifying and evaluating internal and external issues, including relevant national and international biosafety regulations, and the specific needs and expectations of regulatory bodies, employees, and the surrounding community, as they pertain to the laboratory's biorisk management.

Question 5

During an audit of a high-containment research laboratory, a lead auditor reviews the organization\'s biorisk management policy. The policy states: \"Our laboratory is committed to the safe handling of all biological agents and to complying with all relevant national biosafety regulations.\" The auditor notes that the laboratory has a documented biorisk assessment procedure, but it is not explicitly referenced or integrated into the policy statement. Considering the requirements of ISO 35001:2019, what is the most significant deficiency in this policy statement from a lead auditor\'s perspective regarding the establishment of an effective biorisk management system?

Accepted Answer

The policy lacks a clear commitment to establishing and maintaining a biorisk management system that includes systematic biorisk assessment and control measures.

Question 6

During an audit of a high-containment virology laboratory that recently began research on a novel zoonotic virus with an unknown transmission route, the lead auditor observed that while new biosafety cabinets were installed, the existing risk assessment documentation for handling the virus had not been formally updated to reflect the specific challenges posed by this agent. What is the most critical action the lead auditor should verify to ensure compliance with ISO 35001:2019 principles regarding emergent risks and system responsiveness?

Accepted Answer

Verification that a comprehensive re-assessment of biorisks associated with the novel virus has been conducted, leading to updated control measures and documented changes in the risk register.

Question 7

During an audit of a high-containment biosafety laboratory, a lead auditor is reviewing the documented information system for biorisk management. The laboratory has a vast collection of documents, including standard operating procedures (SOPs), risk assessments, training records, incident reports, and equipment maintenance logs. The auditor observes that while many documents exist, there is no clear system for version control, and access to certain critical SOPs appears to be restricted to a few senior personnel without a documented justification for this limitation. Furthermore, the process for updating risk assessments following a minor laboratory incident is inconsistently applied, with some updates logged promptly and others delayed or missing. Considering the requirements of ISO 35001:2019, what is the most significant deficiency identified in the laboratory\'s documented information system for biorisk management?

Accepted Answer

Inadequate control over the creation, update, and accessibility of documented information, impacting its reliability and usability.

Question 8

During an audit of a high-containment biosafety laboratory, a lead auditor is reviewing the implementation of ISO 35001:2019. The laboratory has documented a comprehensive biorisk assessment for its primary research activities involving novel coronaviruses. However, the auditor observes that several newly acquired pieces of equipment, intended for enhanced sample processing, have not been formally integrated into the existing biorisk assessment register. Furthermore, the standard operating procedures (SOPs) for these new instruments do not explicitly reference the identified biorisks or the control measures derived from the assessment. Which of the following audit findings would most accurately reflect a nonconformity related to the integration of biorisk management principles within the laboratory\'s operational framework?

Accepted Answer

Failure to systematically update the biorisk register and associated SOPs to reflect the introduction of new equipment and its associated biorisks.

Question 9

During an audit of a high-containment laboratory engaged in research on emerging zoonotic viruses, what specific aspect of the laboratory\'s operational context, as defined by ISO 35001:2019 Clause 4.2, would be most critical for a lead auditor to scrutinize to ensure the robustness of its biorisk management system?

Accepted Answer

The systematic identification and analysis of external regulatory requirements and internal personnel competency levels related to the specific biological agents handled.

Question 10

During an audit of a high-containment research laboratory specializing in novel viral vector development, a lead auditor observes that while the laboratory has a comprehensive risk assessment matrix, the documented control measures for specific high-risk procedures appear to be generic and lack explicit linkage to the unique characteristics of the engineered viral vectors being handled. Furthermore, there is no clear evidence of periodic review or adaptation of these controls based on emerging scientific literature or internal incident reports related to vector containment. Which of the following findings would represent the most significant non-conformity with the principles of ISO 35001:2019 regarding the effectiveness of the biorisk management system?

Accepted Answer

Failure to demonstrate that risk control measures are specifically tailored and regularly updated to address the unique properties of the biological agents and the specific operational context.

Question 11

During an audit of a high-containment biosafety laboratory, an auditor discovers that a recently characterized viral strain, now classified as requiring Biosafety Level 3 (BSL-3) containment, was initially handled under BSL-2 protocols due to an oversight in the laboratory\'s information dissemination process. While no incident occurred, this situation highlights a potential weakness in the laboratory\'s biorisk management system\'s ability to adapt to evolving scientific understanding and regulatory requirements. What is the most critical action for the lead auditor to take to assess the effectiveness of the laboratory\'s biorisk management system in this context?

Accepted Answer

Verify the documented procedure for evaluating new or updated information on biological agents and integrating it into the laboratory's risk assessments and control measures.

Question 12

During an audit of a high-containment virology laboratory, a lead auditor is reviewing the implementation of ISO 35001:2019. The auditor needs to ascertain the laboratory\'s adherence to the foundational requirements for understanding its operational environment and stakeholder landscape. Which audit approach would most effectively verify the laboratory\'s compliance with the principles outlined in Clause 4.1 (Context of the organization) and Clause 4.2 (Needs and expectations of interested parties)?

Accepted Answer

Examining documented procedures for environmental scanning, stakeholder identification, and the integration of identified issues and requirements into the laboratory's biorisk management system.

Question 13

During an audit of a newly established biosafety laboratory aiming for ISO 35001:2019 certification, the lead auditor is reviewing the initial documentation for the biorisk management system (BRMS). The laboratory director has provided a comprehensive analysis of potential biological hazards, a detailed stakeholder engagement plan, and a draft of the biorisk policy. Which of the following foundational elements should the lead auditor prioritize verifying as the initial documented output of the BRMS establishment process, as per the standard\'s requirements for setting up the system?

Accepted Answer

The documented scope of the biorisk management system

Question 14

During an audit of a high-containment virology laboratory, a lead auditor is reviewing the initial phase of the biorisk management system implementation. The laboratory handles novel zoonotic viruses and operates under stringent national biosafety regulations. Which of the following aspects represents the most critical foundational element for the auditor to verify to ensure the system\'s long-term effectiveness and compliance with ISO 35001:2019?

Accepted Answer

The thoroughness with which the organization has identified and documented its internal and external issues, including regulatory requirements and the specific biological agents handled, and the needs and expectations of relevant interested parties.

Question 15

During an audit of a high-containment virology laboratory, a lead auditor is examining the records of the most recent management review meeting concerning the biorisk management system. The minutes indicate a discussion about a recent minor incident involving a spill of a non-pathogenic surrogate, but they lack any detailed analysis of the effectiveness of the containment procedures that were in place at the time, nor do they explicitly address the adequacy of the training provided to the personnel involved in the incident. Furthermore, the review did not include a forward-looking assessment of emerging biosafety technologies or potential changes in regulatory requirements that might impact the laboratory\'s operations. Based on the requirements of ISO 35001:2019, which of the following would be the most significant finding regarding the management review process?

Accepted Answer

The management review failed to adequately assess the effectiveness of existing biorisk controls and consider future opportunities for improvement as required by the standard.

Question 16

During an audit of a high-containment virology laboratory, an auditor is reviewing the organization\'s approach to understanding its context as per ISO 35001:2019. The laboratory handles several novel zoonotic viruses with potential for airborne transmission, operates under strict national biosafety regulations, and collaborates with international research partners. Which of the following best reflects the auditor\'s primary concern when evaluating the laboratory\'s adherence to Clause 4.1, \"Understanding the organization and its context\"?

Accepted Answer

The extent to which the laboratory has systematically identified and documented external and internal issues that could impact the effectiveness of its biorisk management system, including regulatory compliance and stakeholder expectations.

Question 17

During an audit of a high-containment virology laboratory, an auditor is assessing the effectiveness of the biorisk management system (BRMS) in accordance with ISO 35001:2019. The laboratory has documented procedures for biosafety and biosecurity, and personnel have received initial training. However, the auditor observes that new research projects involving novel viral vectors are initiated without a formal, documented biorisk assessment being completed and approved prior to commencement, and the allocation of specialized containment equipment appears to be based on availability rather than a systematic risk evaluation. Which of the following findings would most strongly indicate a significant nonconformity with the intent of ISO 35001:2019 regarding the integration of biorisk management into operational planning and control?

Accepted Answer

The absence of a documented, pre-project biorisk assessment for new research initiatives, leading to reactive rather than proactive control measure implementation and potential misalignment of resources with identified risks.

Question 18

During an audit of a high-containment biosafety laboratory, an auditor is tasked with evaluating the effectiveness of the organization\'s biorisk management system in accordance with ISO 35001:2019. Specifically, the auditor needs to verify the integration of biorisk management principles into the laboratory\'s daily operational activities as stipulated in Clause 8.3. Which of the following audit findings would most strongly indicate successful integration of biorisk management into operational planning and control?

Accepted Answer

Review of multiple standard operating procedures (SOPs) for common laboratory tasks, demonstrating that specific biorisk mitigation measures, hazard identification, and risk assessment outcomes are explicitly documented and consistently applied within each procedure.

Question 19

During an audit of a high-containment biosafety laboratory, a lead auditor is reviewing the implementation of ISO 35001:2019. The auditor needs to assess the laboratory\'s adherence to the foundational requirements of understanding its operational environment and internal capabilities. Which of the following actions by the auditor would most effectively verify the laboratory\'s compliance with the initial clauses related to establishing the context of the biorisk management system?

Accepted Answer

Reviewing documented evidence of the identification and analysis of relevant external and internal issues that impact the laboratory's biorisk management system, and how these have been integrated into the system's design and operation.

Question 20

During an audit of a high-containment biosafety laboratory, a lead auditor is evaluating the effectiveness of the biorisk management system as per ISO 35001:2019. The auditor has identified that while the laboratory has numerous documented procedures for handling biological agents and maintaining containment, there is no clear, integrated system for managing revisions and ensuring that only the most current versions are accessible to personnel in all work areas. This situation poses a significant risk to operational safety and compliance. What is the most critical deficiency the lead auditor should focus on in their report concerning the laboratory\'s documented information control?

Accepted Answer

The lack of a robust system for controlling documented information, specifically regarding version management and accessibility of current procedures, directly contravenes the intent of ISO 35001:2019 Clause 4.4.

Question 21

During an audit of a high-containment biosafety laboratory, an auditor is evaluating the effectiveness of the laboratory\'s biorisk management system in relation to its operational context. The laboratory handles novel viral agents and is subject to stringent national biosecurity regulations and international shipping protocols. Which of the following actions by the lead auditor best demonstrates adherence to the principles of ISO 35001:2019, specifically concerning the understanding of the organization and its context?

Accepted Answer

Verifying that the laboratory has a documented process for identifying and evaluating external and internal issues, including relevant legal and regulatory requirements, and that these are considered in the development and implementation of the biorisk management system.

Question 22

During an audit of a high-containment biosafety laboratory, a lead auditor is reviewing the initial stages of the biorisk management system (BRMS) implementation. The laboratory director states that they have begun developing standard operating procedures (SOPs) for handling specific pathogens and have procured advanced containment equipment. However, the auditor notes a lack of documented analysis regarding the laboratory\'s operational environment, the specific regulatory landscape it navigates, and the identified needs of its key stakeholders, including regulatory bodies and research collaborators. What fundamental aspect of ISO 35001:2019, as required in the early clauses of the standard, is demonstrably underdeveloped in this scenario, potentially undermining the entire BRMS?

Accepted Answer

Establishing the context of the organization and defining the scope of the biorisk management system.

Question 23

During an audit of a high-containment biosafety laboratory, an auditor is reviewing the initial phase of the biorisk management system (BRMS) implementation. The laboratory director states that they have focused primarily on identifying biological agents and associated risks, and have developed containment strategies based on these. However, there is limited documentation regarding the organization\'s strategic direction, its relationship with regulatory bodies beyond basic compliance, or the specific expectations of its funding agencies and the local community regarding public health protection. Which aspect of ISO 35001:2019 has been most significantly overlooked in this initial phase?

Accepted Answer

Establishing the context of the organization and identifying interested parties and their requirements.

Question 24

During an audit of a high-containment biosafety laboratory, an auditor is reviewing the organization\'s approach to establishing the scope and context of its biorisk management system, as per ISO 35001:2019. The laboratory handles novel viral agents and is subject to national biosafety regulations and international shipping guidelines. Which of the following actions by the auditor would best verify the organization\'s compliance with the foundational requirements for understanding its operational environment and stakeholders?

Accepted Answer

Examining documented evidence of how the laboratory systematically identified and analyzed relevant external factors, such as evolving biosafety legislation and emerging biotechnologies, and internal factors, such as staff competency and infrastructure limitations, and how these informed the development of its biorisk management policy and objectives.

Question 25

During an audit of a biosafety level 3 (BSL-3) facility, a lead auditor is examining the documented procedures following a recent, albeit minor, containment breach involving a non-pathogenic surrogate organism. The breach was contained quickly with no personnel exposure, but it highlighted a potential weakness in the airlock interlock system. The facility\'s management has implemented immediate corrective actions to address the interlock, but the auditor needs to assess the broader implications for the biorisk management system. What is the most appropriate action for the lead auditor to take regarding the facility\'s adherence to ISO 35001:2019 principles in this context?

Accepted Answer

Verify that the incident has triggered a comprehensive review of the entire biorisk management system, including an assessment of the effectiveness of existing controls, the adequacy of emergency response procedures, and the need for updated risk assessments and training.

Question 26

During an audit of a high-containment biosafety laboratory, a lead auditor observes that while the laboratory has a comprehensive list of potential biological hazards and associated control measures documented in its risk assessments, there is a noticeable disconnect between the documented controls and the actual practices observed during a walk-through. For instance, specific personal protective equipment (PPE) requirements for handling a particular viral agent are detailed in the standard operating procedure (SOP), but several technicians were seen not consistently adhering to these requirements. What is the most critical finding for the lead auditor to report regarding the effectiveness of the laboratory\'s biorisk management system in this scenario?

Accepted Answer

Failure to ensure consistent implementation and adherence to documented biorisk control measures, indicating a breakdown in the operationalization of the risk management system.

Question 27

During an audit of a high-containment biosafety laboratory, a lead auditor is reviewing the implementation of the biorisk management policy. The laboratory director states that the policy is clearly documented and accessible on the company intranet. However, the auditor observes that several key personnel in the research and operations departments seem unaware of specific commitments within the policy related to the hierarchy of controls and the process for reporting near misses. What is the most critical deficiency the auditor should identify regarding the laboratory\'s adherence to ISO 35001:2019, specifically concerning the biorisk management policy?

Accepted Answer

Failure to ensure the biorisk policy is effectively communicated and understood by all relevant personnel, thereby undermining its integration into daily operations and management commitment.

Question 28

During an audit of a high-containment biosafety laboratory, a lead auditor is reviewing the personnel competence records. The laboratory director states that all staff are highly experienced and have been trained on general laboratory safety protocols. However, there is no documented process for identifying specific biorisk management competencies required for each role, nor is there a system for regularly assessing the effectiveness of training or experience in relation to the specific biological agents handled and the containment levels employed. Which of the following represents the most significant nonconformity with ISO 35001:2019, Clause 7.2 (Competence)?

Accepted Answer

Absence of a documented, systematic process for determining, acquiring, and evaluating the necessary competence for personnel involved in biorisk management activities.

Question 29

During an audit of a high-containment biosafety laboratory, a lead auditor is assessing the implementation of ISO 35001:2019 requirements. The auditor has reviewed the laboratory\'s documented procedures for personnel competence and observed several technicians performing complex manipulations with biological agents. The auditor needs to determine the most critical aspect to verify regarding personnel competency to ensure the effectiveness of the biorisk management system. Which of the following actions by the lead auditor would provide the most robust evidence of effective competence assurance for biorisk management?

Accepted Answer

Verifying that training records demonstrate completion of all mandatory biosafety training modules and that competency assessments are conducted periodically.

Question 30

During an audit of a high-containment research laboratory, an auditor is reviewing the biorisk management system\'s effectiveness in controlling the handling of *Bacillus anthracis*. The laboratory\'s documented procedures outline the use of Class II Type B2 biosafety cabinets and specific autoclaving protocols for waste decontamination. However, the auditor discovers that while these controls are generally implemented, there is no explicit, documented risk assessment specifically detailing the hazards associated with *Bacillus anthracis* and the rationale for selecting these particular control measures within the laboratory\'s formal risk assessment register. What is the most critical finding for the auditor to report regarding the laboratory\'s adherence to ISO 35001:2019 principles?

Accepted Answer

Failure to demonstrate a documented risk assessment specifically for *Bacillus anthracis*, which is a prerequisite for validating the adequacy of implemented control measures.

ISO 35001:2019 - Biorisk Management for Laboratories Lead Auditor Free Practice Test — 30 Questions

A lot more is already mapped out

About the ISO 35001:2019 - Biorisk Management for Laboratories Lead Auditor Certification